Skip to main content

Advertisement

Log in

Hematopoietic Cell Transplant for CD40 Ligand Deficiency—Comparing Busulfan Versus Treosulfan

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data Availability

Clinical data files are stored at the Great North Children’s Hospital and may be shared according to institutional guidelines.

References

  1. Ferrua F, Galimberti S, Courteille V, Slatter MA, Booth C, Moshous D, et al. Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study. J Allergy Clin Immunol. 2019;143:2238–53.

    Article  CAS  PubMed  Google Scholar 

  2. de la Morena MT, Leonard D, Torgerson TR, Cabral-Marques O, Slatter M, Aghamohammadi A, et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. J Allergy Clin Immunol. 2017;139:1282–92.

    Article  PubMed  Google Scholar 

  3. Mitsui-Sekinaka K, Imai K, Sato H, Tomizawa D, Kajiwara M, Nagasawa M, et al. Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan. J Allergy Clin Immunol. 2015;136:1018–24.

    Article  PubMed  Google Scholar 

  4. Uygun DFK, Uygun V, Karasu GT, Daloğlu H, Öztürkmen SI, Çelmeli F, et al. Hematopoietic stem cell transplantation in CD40 ligand deficiency: a single-center experience. Pediatr Transplant. 2020;24:e13768.

  5. Allewelt H, Martin PL, Szabolcs P, Chao N, Buckley R, Parikh S. Hematopoietic stem cell transplantation for cd40 ligand deficiency: single institution experience. Pediatr Blood Cancer. 2015;62:2216–22.

Download references

Author information

Authors and Affiliations

Authors

Contributions

ARG and MAS conceived the study, and VAC and SHL collected and analyzed the data of the patients. VAC, SHL, and ARG wrote the manuscript. VAC, SHL, TF, MAS, and ARG all reviewed and edited the manuscript.

Corresponding author

Correspondence to Andrew R. Gennery.

Ethics declarations

Ethics Approval

No formal ethical approval was obtained for this retrospective study.

Consent to Participate

Freely given written informed consent was obtained from participants/parents or legal guardians for data collection and participation as per institutional practice.

Consent for Publication

Freely given written informed consent was obtained from participants/parents or legal guardians for publication as per institutional practice.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Vicky-Anne Carruthers and Su Han Lum are joint first authors.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carruthers, VA., Lum, S.H., Flood, T. et al. Hematopoietic Cell Transplant for CD40 Ligand Deficiency—Comparing Busulfan Versus Treosulfan. J Clin Immunol 42, 703–705 (2022). https://doi.org/10.1007/s10875-021-01200-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-021-01200-6

Navigation